Financial News reports that Blago Baychev's PharVision gained about 6% in September, after being roughly 1% down through August. The former Citadel trader's firm reportedly manages about $50 million and is seeking another $50 million. A source attributes the rebound to AI-generated US-equity long/short signals. The account supplies neither audited attribution nor enough fee/share-class detail to make that an independently established AI-performance result.